TEMECULA, Calif., March 23, 2017 -- Holy Grail Company is proud to announce the approval by FINRA for the official name change from FLEXWEEK, INC to HOLY GRAIL COMPANY, and the symbol has now changed on the OTC markets from (OTC:FXWK) to (OTC:HGRL).
|
|||
Following the announcement as of today, March 23, 2017, the name and symbol change will be effective Friday, March 24th, 2017.
“The company is very excited for the approval and could not be happier with the symbol (HGRL). We are looking forward to being in a position now to create a cash positive position for the company and allow it to exercise its branding and marketing strategies,” said Co-CEO Jason Golec, Holy Grail Company.
“It is a great feeling after all of the hard work to get us to this point. Thank you to our great team for their hard work and dedication to achieve this step,” said Co-CEO Edward Quiroz, Holy Grail Company.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause Holy Grail Company actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. Holy Grail Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional uncertainties that could impact Holy Grail Company forward-looking statements, please see Holy Grail Company’s filings on OTC Markets.
For more information please visit us at: www.holygrailcompany.com Phone: 866-699-5396


Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Starlink Internet Remains Active in Iran Despite Nationwide Blackout
AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration
Lynas CEO Amanda Lacaze to Retire After 12 Years as Rare Earths Demand Grows
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026
BlackRock to Cut Around 250 Jobs as CEO Larry Fink Pushes Strategic Shift
SK Hynix to Invest $13 Billion in Advanced Chip Packaging Plant as AI Memory Demand Surges
Anthropic Launches HIPAA-Compliant Healthcare Tools for Claude AI Amid Growing Competition
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside
HSBC Expands UAE Presence With New Asset Management Business and Onshore Funds
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges
Rio Tinto–Glencore Talks Spark Pressure on BHP as Copper Fuels Mining Mega Deals
Allegiant to Acquire Sun Country Airlines in $1.5 Billion Deal to Expand U.S. Leisure Travel Network
NYC Nurses Strike Shuts Down 10 Private Hospitals as 15,000 Demand Safer Staffing and Benefits
Trump Pushes Tech Giants to Absorb AI Data Center Power Costs, Citing Microsoft Changes
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks 



